Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 3
2010 1
2011 2
2012 2
2013 1
2014 1
2016 1
2018 2
2019 1
2021 1
2023 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
[Ataxia-telangiectasia].
Paravisini A, Gurbindo MD, Sánchez Román S. Paravisini A, et al. Med Clin (Barc). 2012 Mar 17;138(6):249-53. doi: 10.1016/j.medcli.2011.06.006. Epub 2011 Sep 21. Med Clin (Barc). 2012. PMID: 21940004 Review. Spanish. No abstract available.
Comparative assessment of pharmacokinetics, and pharmacodynamics between RTXM83™, a rituximab biosimilar, and rituximab in diffuse large B-cell lymphoma patients: a population PK model approach.
Candelaria M, Gonzalez D, Fernández Gómez FJ, Paravisini A, Del Campo García A, Pérez L, Miguel-Lillo B, Millán S. Candelaria M, et al. Among authors: paravisini a. Cancer Chemother Pharmacol. 2018 Mar;81(3):515-527. doi: 10.1007/s00280-018-3524-9. Epub 2018 Jan 24. Cancer Chemother Pharmacol. 2018. PMID: 29362903 Clinical Trial.
The Burden Of Chronic Urticaria In Europe: A Systematic Literature Review.
Betoret I, Lambert C, Paravisini A, Tribaldos M, Paz S, Lizán L. Betoret I, et al. Among authors: paravisini a. Value Health. 2014 Nov;17(7):A611-2. doi: 10.1016/j.jval.2014.08.2144. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202133 Free article. No abstract available.
Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study (STELLA).
Trukhin D, Poddubskaya E, Andric Z, Makharadze T, Bellala RS, Charoentum C, Yañez Ruiz EP, Fulop A, Hyder Ali IA, Syrigos K, Katgi N, Lopez Chuken YA, Rumyana I, Reyes-Igama J, Costamilan RC, Del Campo García A, Florez A, Paravisini A, Millan S; STELLA Investigators. Trukhin D, et al. Among authors: paravisini a. BioDrugs. 2021 Jul;35(4):429-444. doi: 10.1007/s40259-021-00483-w. Epub 2021 Apr 29. BioDrugs. 2021. PMID: 33914256 Free PMC article. Clinical Trial.
Rituximab biosimilar RTXM83 versus reference rituximab in combination with CHOP as first-line treatment for diffuse large B-cell lymphoma: a randomized, double-blind study.
Candelaria M, González DE, Delamain MT, Bär DO, Beniwal SK, Dasappa L, Flores DH, Querol J, Guan TS, Lipatov ON, Volodicheva EM, Patel M, Safaee Nodehi SR, Fogliatto L, Paravisini A, Perez Diaz L; RTXM83 study. Candelaria M, et al. Among authors: paravisini a. Leuk Lymphoma. 2019 Dec;60(14):3375-3385. doi: 10.1080/10428194.2019.1633632. Epub 2019 Jul 4. Leuk Lymphoma. 2019. PMID: 31272251 Free article. Clinical Trial.
Pericardial tamponade in a patient with polymyalgia rheumatica.
Calvo E, Becerra E, López-Longo FJ, Cabrera FJ, Carreño L, Paravisini A, Cebollero M, Pinilla B, Muiño A. Calvo E, et al. Among authors: paravisini a. Clin Exp Rheumatol. 2009 Jan-Feb;27(1 Suppl 52):S83-5. Clin Exp Rheumatol. 2009. PMID: 19646352
Bevacizumab biosimilar BEVZ92 versus reference bevacizumab in combination with FOLFOX or FOLFIRI as first-line treatment for metastatic colorectal cancer: a multicentre, open-label, randomised controlled trial.
Romera A, Peredpaya S, Shparyk Y, Bondarenko I, Mendonça Bariani G, Abdalla KC, Roca E, Franke F, Melo Cruz F, Ramesh A, Ostwal V, Shah P, Rahuman SA, Paravisini A, Huerga C, Del Campo García A, Millán S. Romera A, et al. Among authors: paravisini a. Lancet Gastroenterol Hepatol. 2018 Dec;3(12):845-855. doi: 10.1016/S2468-1253(18)30269-3. Epub 2018 Sep 24. Lancet Gastroenterol Hepatol. 2018. PMID: 30262136 Clinical Trial.
Omalizumab for the treatment of atopic dermatitis.
Fernández-Antón Martínez MC, Leis-Dosil V, Alfageme-Roldán F, Paravisini A, Sánchez-Ramón S, Suárez Fernández R. Fernández-Antón Martínez MC, et al. Among authors: paravisini a. Actas Dermosifiliogr. 2012 Sep;103(7):624-8. doi: 10.1016/j.ad.2011.07.013. Epub 2011 Nov 3. Actas Dermosifiliogr. 2012. PMID: 22056257 Free article. Clinical Trial. English, Spanish.
17 results